Recruiting studies: Grade Iii Meningioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Phase 2 · 1 location(s) · Mayo Clinic · NCT04082520 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · 215 location(s) · NRG Oncology · NCT03180268 Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
NA · 1 location(s) · Emory University · NCT04278118 NEO100 and High-Grade Meningioma
Phase 2 · 5 location(s) · Neonc Technologies, Inc. · NCT05023018 Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3
Phase 2 · 8 location(s) · Northwestern University · NCT02847559 A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Phase 2 · 12 location(s) · Exelixis · NCT07428616 Abemaciclib in Newly Diagnosed Meningioma Patients
Phase 2 · 1 location(s) · Nader Sanai · NCT05940493

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.